Atlas Trials

Concomitant Chemo-radiotherapy Plus VIDL Chemotherapy in NK/T-cell Lymphoma

Clinical trial NCT01007526 · COMPLETED

Trial details

NCT number
NCT01007526
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
NK/T-cell Lymphoma of Nasal Cavity
Start date
2008-04-01
Primary completion
2012-12-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.